{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-007069","form_type":"8-K","ticker":null,"cik":"0001603207","company_name":"Notable Labs, Ltd.","filed_at":"2023-03-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.793942+00:00","generated_at":"2026-06-18T07:04:19.349748+00:00","sec_items":["2.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"VBL sells manufacturing facility for $7.1M to Aleph Farms; proceeds to support merger closing condition","bullets":["Sold manufacturing facility in Modi’in, Israel, and related assets to Aleph Farms for $7.1 million cash.","Proceeds intended to help meet $15.0M minimum net cash closing condition for proposed merger with Notable Labs (announced Feb 23, 2023).","Asset sale completed March 9, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-007069","json":"https://secwatch.observer/filing/0001493152-23-007069.json","markdown":"https://secwatch.observer/filing/0001493152-23-007069.md","text":"https://secwatch.observer/filing/0001493152-23-007069.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1603207/000149315223007069/0001493152-23-007069-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1603207/000149315223007069/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T07:04:19.349748+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b982c81e0b74a657f4303a7adbeee981d67475f6","claim":"Notable Labs, Ltd. completed a disposition involving Aleph Farms for $7.1 million in cash (closed 2023-03-09).","evidence_excerpt":"On March 9, 2023, Vascular Biogenics Ltd. (“ VBL ”) completed the previously announced sale of its manufacturing facility in Modi’in, Israel, and certain related assets, for $7.1 million in cash (the “ Asset Sale ”), pursuant to that certain Asset Purchase Agreement (the “ Purchase Agreement ”) entered into with Aleph Farms, an Israel-based food technology company.","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1603207/000149315223007069/0001493152-23-007069-index.htm","confidence":0.95,"family_label":"M&A Transactions","details":[{"label":"Action","value":"disposition"},{"label":"Counterparty","value":"Aleph Farms"},{"label":"Consideration","value":"$7.1 million in cash"},{"label":"Closing","value":"2023-03-09"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}